查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988474

主動脈瘤市場：2026-2032年全球市場預測（按類型、治療方法、器材類型、適應症、患者年齡層、性別和最終用戶分類）

Aortic Aneurysm Market by Aneurysm Type, Treatment Modality, Device Type, Indication, Patient Age Group, Gender, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，主動脈瘤市場價值將達到 52.2 億美元，到 2026 年將成長至 56.9 億美元，到 2032 年將達到 96.3 億美元，複合年成長率為 9.14%。

主要市場統計數據
基準年 2025 52.2億美元
預計年份：2026年 56.9億美元
預測年份 2032 96.3億美元
複合年成長率 (%) 9.14%

本導言部分概述了影響主動脈瘤治療和相關人員決策的臨床實踐、技術和醫療保健服務的發展趨勢。

主動脈瘤的治療正處於外科創新、人口結構變化和醫療服務模式演變的交匯點。近年來，臨床實務穩步轉向微創治療，同時影像學和醫療設備技術也取得了長足進步，使得降低圍手術全期風險變得日益重要。這些趨勢與人口老化和心血管合併症負擔日益加重的背景下交織在一起，既造成了持續的臨床需求，也使得人們更加關注安全、長期有效且經濟的治療方案。

對臨床創新、醫療服務格局的轉變以及監管重點如何重塑所有相關人員。

由於技術成熟、醫療服務環境轉變以及相關人員價值觀的重新定義，主動脈瘤的治療現狀正在經歷一場變革。微創血管內修復術，得益於影像精度的提高、導航系統的改進以及可治療以往無法手術部位的模組化血管支架的設計，已從一種小眾選擇發展成為多種解剖類型主動脈瘤的標準治療方案。這些進步輔以術前術後最佳化技術和促進復原的通訊協定，從而縮短了住院時間並減少了術後併發症，進而改變了臨床決策的標準。

詳細分析 2025 年美國關稅變化將如何影響整個主動脈瘤治療生態系統中醫療設備的採購、製造策略和購買決策。

美國於2025年實施的關稅調整，為參與主動脈瘤治療的醫療設備製造商、醫療系統和經銷商的供應鏈計算引入了新的變數。許多用於血管內和開放式手術修復的醫療設備和組件都來自世界各地，進口關稅的變化可能導致血管支架移植物、人工血管及相關輸送組件的總體成本增加。這些成本壓力會波及整個採購流程，迫使醫院供應鏈團隊重新談判合約、重新評估供應商多元化策略，並考慮某些生產和滅菌流程在地化的可行性。

透過細分主導洞察，將治療方法、解剖複雜性、醫療保健環境和患者人口統計數據聯繫起來，從而指導可操作的臨床和商業策略。

細分市場分析揭示了影響治療方法選擇、醫療設備需求和醫療機構採納的清晰臨床路徑和商業性考慮。基於治療方法，臨床醫生會將血管內修復與開放手術修復進行比較，並考慮患者的解剖結構和生理耐受力。在血管內技術中，配備先進輸送平台的血管支架系統正被擴大用於擴大應用範圍；而在開放手術修復中，生物導管和合成血管移植物仍然被廣泛使用，其耐久性和特定的解剖結構要求決定了手術方式的選擇。

區域評估突顯了醫療保健基礎設施、報銷制度和臨床實踐的差異如何影響全球主要地區的主動脈瘤治療。

區域趨勢導致臨床實踐、基礎設施建設和監管預期存在顯著差異，進而影響主動脈瘤治療的實施方式和產品的商業化。在美洲，微創手術備受推崇，並擁有完善的公共和私人醫療保險體系。先進的影像網路和高容量的三級醫療機構支援新型血管內移植物和複雜開窗解決方案的快速應用，而低風險、選擇性的手術病例也逐漸在門診環境中得到認可。

從產業角度概述創新管道、供應鏈敏捷性和證據產生如何塑造醫療設備製造商之間的競爭差異化。

主動脈瘤領域的企業策略著重於持續創新、臨床證據的累積和營運規模的擴大。領先的醫療設備開發商正優先投資於新一代血管支架結構、低輪廓輸送系統和材料科學，以改善長期治療效果並擴大其解剖學適用範圍。醫療設備創新者與契約製造和影像技術公司之間的策略合作日益普遍，從而能夠提供植入性能與先進導航和術中成像相結合的整合解決方案。

為協調產品開發、供應鏈韌性和基於價值的商業化，以加速產品推廣和臨床應用，提出切實可行的策略建議。

產業領導者應採取多管齊下的策略，使產品創新與醫療服務趨勢、監管預期和採購實際情況相契合。首先，他們應優先發展模組化、解剖結構適應性強的器材平台，以降低手術複雜性，擴大微創治療的適用人群，從而促進其在各種醫療環境中的廣泛應用。其次，他們應投資於可靠的真實世界數據（REW）收集和註冊系統，以加快保險公司的接受度，證明產品的長期安全性，並根據臨床實際情況推動產品的迭代改進。

對用於獲取有關主動脈瘤治療的臨床、商業性和供應鏈見解的定性和定量調查方法的整合進行透明的解釋。

本執行摘要的調查方法融合了定性和定量方法，以確保得出嚴謹且基於證據的見解。主要資訊來源包括對血管外科醫生、介入醫生、醫院採購經理和醫療設備監管專家的訪談，以了解目前的臨床實踐、醫療設備選擇標準以及推廣應用的障礙。除了這些臨床層面的觀點外，與供應鏈和商業領導者的討論也提供了關於生產製造方面的考慮、分銷趨勢以及近期貿易政策影響的見解。

簡潔結論總結了臨床創新、供應鏈趨勢和策略挑戰之間的相互作用，這些因素將決定主動脈瘤治療的未來成功。

主動脈瘤治療正處於一個轉折點，技術創新、人口壓力和不斷變化的醫療模式相互交織，為臨床醫生、製造商和醫療系統帶來了機會和挑戰。微創血管內治療策略的興起擴大了可治療疾病的範圍，並改變了資源分配，而器械開發商則透過針對性的創新來應對解剖學挑戰並提高器械的長期耐用性。同時，包括貿易發展和保險公司審查在內的商業性和政策趨勢，也影響籌資策略和市場准入方式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：主動脈瘤市場：依動脈瘤類型分類

  • 腹部主動脈血管瘤
    • 下腎
    • 腎旁
    • 腎上腺上部
  • 胸主動脈瘤
    • 上升部分
    • 下降部分
    • 胸部 腹部

第9章 主動脈瘤市場：依治療方法

  • 血管內修復
  • 透過開放式手術進行修復
    • 生物血管移植物
    • 人工血管移植

第10章：主動脈瘤市場：依器材類型分類

  • 血管支架
  • 人工血管移植

第11章：主動脈瘤市場：依適應症分類

  • 已安排的手術
  • 爆裂修復

第12章：主動脈瘤市場：依病患年齡層別分類

  • 65歲或以上
  • 65歲以下

第13章 主動脈瘤市場：性別

  • 女士
  • 男性

第14章 主動脈瘤市場：依最終用戶分類

  • 門診手術中心
    • 循環系統中心
    • 獨立外科中心
  • 醫院
    • 綜合醫院
    • 血管專科中心
    • 三級醫療醫院

第15章：主動脈瘤市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 主動脈瘤市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 主動脈瘤市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國：主動脈瘤市場

第19章 中國：主動脈瘤市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Altura Medical Inc.
  • Artivion, Inc.
  • Bentley InnoMed GmbH
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • Cardinal Health company
  • Cook Medical Inc.
  • CryoLife, Inc.
  • Endologix Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Lemaitre Vascular Inc.
  • LifeTech Scientific Corporation
  • LivaNova PLC
  • Lombard Medical, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Phenox GmbH
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-D1342F184FD2

The Aortic Aneurysm Market was valued at USD 5.22 billion in 2025 and is projected to grow to USD 5.69 billion in 2026, with a CAGR of 9.14%, reaching USD 9.63 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.22 billion
Estimated Year [2026] USD 5.69 billion
Forecast Year [2032] USD 9.63 billion
CAGR (%) 9.14%

An overarching introduction that frames the evolving clinical, technological, and delivery dynamics shaping aortic aneurysm treatment and stakeholder decision-making

Aortic aneurysm management sits at the intersection of surgical innovation, demographic shifts, and evolving healthcare delivery models. Recent years have seen the steady migration of clinical preference toward less invasive therapies, concurrent advances in imaging and device technology, and a heightened emphasis on perioperative risk mitigation. These dynamics converge against a backdrop of an ageing population with rising cardiovascular comorbidity burden, creating sustained clinical demand while simultaneously intensifying the focus on safety, long-term durability, and cost-effective pathways for intervention.

Clinicians and health system leaders are now navigating a more complex therapeutic landscape in which endovascular options must be balanced against open repair approaches based on anatomical suitability, patient frailty, and access-to-care considerations. Device designers are responding with increasingly sophisticated stent graft architectures, refined delivery systems, and adjunctive tools to address challenging anatomies such as short-necked infrarenal aneurysms and complex thoracoabdominal lesions. At the same time, payors and hospital administrators are scrutinizing procedural site selection and resource utilization, prompting closer evaluation of ambulatory surgery centers and streamlined care protocols.

This executive summary synthesizes current clinical trends, regulatory and commercial shifts, and provider-level strategic implications to support clinicians, manufacturers, and investors in making informed decisions. The analysis emphasizes actionable insights into modality choice, device differentiation, end-user adoption patterns, and regional variations that are shaping the path forward for aortic aneurysm care.

An in-depth analysis of how clinical innovation, care setting transitions, and regulatory emphasis are reshaping aortic aneurysm treatment paradigms across stakeholders

The landscape of aortic aneurysm care is undergoing transformative shifts driven by technological maturation, changing care settings, and the reframing of value across stakeholders. Minimally invasive endovascular repair has progressed from a niche alternative to a default option for many anatomies, supported by improved imaging fidelity, navigation systems, and modular stent graft designs that address previously inoperable segments. These advances are complemented by perioperative optimization techniques and enhanced recovery protocols that reduce length of stay and procedural morbidity, thereby altering the calculus of clinical decision-making.

Concurrently, device innovation is moving toward personalized solutions, including fenestrated and branched endografts, low-profile delivery systems, and materials engineered for long-term durability and reduced thrombogenicity. These innovations expand candidacy for endovascular approaches, particularly among older or comorbid patients who would face higher risks with open surgical repair. The shift is not purely technological; it reflects an ecosystem change where multidisciplinary teams, including vascular surgery, interventional radiology, and cardiac surgery, increasingly collaborate to tailor therapy to patient-specific anatomy and risk profiles.

Health systems are also redefining care pathways, directing lower-risk elective procedures to ambulatory settings and employing telemedicine and remote monitoring for follow-up surveillance. This decentralization of care pressures device manufacturers to standardize training, simplify deployment, and ensure consistent outcomes across disparate settings. Lastly, regulatory emphasis on post-market surveillance and real-world evidence is prompting companies to invest in registries and longitudinal studies, which in turn inform clinical guidelines and payer coverage policies. Together, these shifts create both opportunity and competitive pressure for stakeholders to adapt strategy, investment, and product development roadmaps.

A detailed exploration of how the 2025 United States tariff changes have influenced device sourcing, manufacturing strategies, and procurement decisions across the aortic aneurysm ecosystem

Tariff adjustments implemented in the United States in 2025 introduced a new variable into the supply chain calculus for medical device manufacturers, health systems, and distributors involved in aortic aneurysm care. Many devices and components used in endovascular and open surgical repairs are sourced globally, and changes in import duties can result in increased landed costs for stent grafts, synthetic conduits, and ancillary delivery components. These cost pressures ripple through procurement processes, prompting hospital supply chain teams to renegotiate contracts, reassess supplier diversification strategies, and evaluate the feasibility of localizing certain manufacturing or sterilization processes.

The cumulative impact of the tariff measures has prompted manufacturers to reassess their global sourcing footprints, with some prioritizing regional production hubs to mitigate exposure to trade fluctuations. For devices that rely on specialized raw materials or implants produced by a limited set of suppliers, tariffs have amplified the need for transparent cost structures and contingency planning. Health systems facing constrained operating budgets may respond by enhancing value-based contracting, extending device reuse policies within regulatory allowances, or prioritizing procedural modalities that demonstrate stronger cost-effectiveness in their local contexts.

Regulatory and reimbursement bodies have also taken notice, and the interplay between import duties and pricing has the potential to alter negotiations around bundled payments and procedural reimbursement. For international suppliers, tariff-induced pricing changes may slow market entry or shift commercialization timelines, particularly for high-complexity devices that require substantial clinical evidence prior to adoption. Ultimately, the 2025 tariff environment underscores the importance of supply-chain resilience, flexible manufacturing strategies, and closer collaboration between manufacturers and providers to preserve access to life-saving aortic aneurysm interventions while managing economic impacts.

Segment-driven insights that connect treatment modalities, anatomical complexity, care settings, and patient demographics to actionable clinical and commercial strategies

Segmentation analysis reveals distinct clinical pathways and commercial considerations that influence treatment selection, device demand, and provider adoption. Based on treatment modality, clinicians weigh endovascular repair against open surgical repair by considering patient anatomy and physiological resilience; endovascular techniques increasingly leverage stent graft systems with advanced delivery platforms to expand applicability, while open surgical repair continues to rely on both biological conduits and synthetic vascular grafts where durability and specific anatomical requirements dictate approach.

When viewed through the lens of aneurysm type, abdominal aortic aneurysms and thoracic aortic aneurysms present different technical challenges and device requirements. Abdominal presentations are further stratified by infrarenal, juxtarenal, and suprarenal locations, each demanding unique fixation and sealing strategies, whereas thoracic presentations span ascending, descending, and thoracoabdominal segments that often require branched or fenestrated designs to preserve branch vessel integrity. These anatomical distinctions drive product development priorities, imaging protocols, and operator training needs.

End-user segmentation highlights divergent adoption curves and procedural settings. Ambulatory surgery centers, including cardiology-centered facilities and standalone surgery centers, are increasingly attractive for lower-risk, elective interventions that benefit from streamlined throughput and lower overhead. Conversely, hospitals, whether general, specialized vascular centers, or tertiary care institutions, maintain primacy for high-complexity cases and ruptured presentations that require multidisciplinary resources and critical care capabilities.

Device type segmentation isolates stent graft systems and synthetic vascular grafts as core product categories, each with unique regulatory pathways, sterilization requirements, and surgeon preferences. Indication-based segmentation differentiates elective repairs, where optimization of recovery and cost containment are priorities, from rupture repairs, which demand immediate access to robust devices and emergent care pathways. Patient demographics further nuance demand patterns, with an older cohort driving higher procedural volume and anatomical complexity; gender differences shape risk stratification and anatomical fit considerations, necessitating inclusive design and evidence generation across populations.

A regional assessment highlighting how divergent healthcare infrastructures, reimbursement approaches, and clinical practices shape aortic aneurysm care across major global geographies

Regional dynamics produce meaningful variation in clinical practice, infrastructure readiness, and regulatory expectations that affect how aortic aneurysm care is delivered and how products are commercialized. In the Americas, there is a strong emphasis on minimally invasive approaches coupled with robust private and public payer systems; advanced imaging networks and high-volume tertiary centers support rapid adoption of novel endografts and complex fenestrated solutions, while ambulatory settings are progressively absorbing lower-risk elective cases.

Europe, Middle East & Africa present a heterogeneous landscape where western European markets emphasize guideline-driven adoption and centralized specialized vascular centers, and emerging markets across the Middle East and Africa grapple with infrastructure constraints and variable access to advanced devices. Regulatory alignment with regional authorities and investments in training and centers of excellence are critical to expanding reach across these diverse healthcare systems.

Asia-Pacific demonstrates accelerated uptake in innovation in several urbanized markets that combine high procedure volumes with expanding ambulatory infrastructures. Local manufacturing capacities and partnerships with global manufacturers are shaping access and price dynamics, while demographic trends and public health initiatives are increasing screening and early detection efforts. Across regions, differences in reimbursement structures, clinical guideline adoption, and workforce availability create distinct strategic imperatives for manufacturers and providers seeking sustainable growth and clinical impact.

An industry-focused overview of how innovation pipelines, supply chain agility, and evidence generation are shaping competitive differentiation among device manufacturers

Corporate strategy in the aortic aneurysm domain centers on sustained innovation, clinical evidence generation, and operational scale. Leading device developers prioritize investments in next-generation stent graft architectures, low-profile delivery systems, and materials science to improve long-term outcomes and broaden anatomical applicability. Strategic alliances between device innovators and contract manufacturers or imaging technology firms are increasingly common, enabling integrated solutions that combine implant performance with advanced navigation and intraoperative imaging.

Investment in post-market surveillance and real-world data initiatives has become a differentiator, supporting regulatory submissions, payer negotiations, and clinician confidence. Firms that can demonstrate comprehensive training programs, robust customer support, and streamlined logistics achieve higher penetration across ambulatory and hospital settings. Meanwhile, smaller and emerging medtech companies focus on niche innovations-such as branched configurations for complex thoracoabdominal repairs or biologically optimized graft materials-positioning themselves for acquisition or strategic partnerships with larger players.

Supply-chain agility and regional manufacturing presence influence competitive positioning, particularly in areas affected by trade policy shifts. Companies that proactively localize production or diversify supplier networks reduce exposure to tariff volatility and distribution bottlenecks. Additionally, those that invest in digital tools for follow-up surveillance, patient-reported outcomes, and remote monitoring create differentiated value propositions for health systems prioritizing longitudinal care and cost containment.

Actionable strategic recommendations that align product development, supply chain resilience, and value-based commercialization to accelerate adoption and clinical impact

Industry leaders should adopt a multi-pronged strategy that aligns product innovation with care delivery trends, regulatory expectations, and procurement realities. First, prioritize modular and anatomically adaptable device platforms that reduce procedure complexity and expand the pool of patients eligible for less invasive treatment, thereby enabling broader adoption across diverse care settings. Second, invest in robust real-world evidence generation and registries to accelerate payer acceptance, validate long-term safety, and inform iterative product improvements that are grounded in clinical practice realities.

Third, strengthen supply-chain resilience by diversifying supplier bases, exploring regional production hubs, and developing contingency plans for component sourcing to mitigate the impact of trade policy shifts. Fourth, tailor commercial approaches to end-user segmentation by offering targeted training and support programs for ambulatory surgery centers, and by providing integrated clinical pathways for tertiary hospitals managing complex rupture cases. Fifth, collaborate with health systems to pilot bundled-care models and outcome-based contracts that align reimbursement with value delivered, thus improving access while demonstrating cost-effectiveness.

Finally, foster multidisciplinary clinician engagement and invest in education that promotes appropriate patient selection, surveillance protocols, and secondary prevention; this clinician-centric approach supports safer adoption of novel devices and strengthens long-term patient outcomes. These combined actions will position organizations to capture clinical and commercial opportunities while managing operational risks.

A transparent explanation of the blended qualitative and quantitative research approach used to derive clinical, commercial, and supply chain insights for aortic aneurysm care

The research methodology underpinning this executive summary integrates qualitative and quantitative approaches to ensure rigorous, evidence-based insights. Primary inputs include expert interviews with vascular surgeons, interventionalists, hospital procurement leaders, and device regulatory specialists to capture current clinical practice, device preferences, and adoption barriers. These clinician-level perspectives are supplemented by discussions with supply-chain and commercial leaders to understand manufacturing considerations, distribution dynamics, and the implications of recent trade policies.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory guidance documents, and professional society position statements to validate clinical trends and device-specific performance characteristics. Where appropriate, registry data and published post-market surveillance reports were analyzed to assess safety signals and durability considerations, and findings were triangulated across multiple sources to enhance robustness. The segmentation framework was applied to map product types, indications, end-user settings, and patient cohorts to ensure that insights reflect the diversity of clinical pathways and commercial channels.

Finally, analytic rigor was maintained through cross-validation of thematic findings with independent experts and iterative refinement of conclusions to reflect both clinical nuance and commercial realism. This blended methodology supports actionable recommendations while acknowledging areas where evidence remains emergent and where ongoing surveillance will be required.

A concise conclusion summarizing the interplay of clinical innovation, supply chain dynamics, and strategic imperatives that will determine future success in aortic aneurysm care

Aortic aneurysm care is at an inflection point where technological innovation, demographic pressures, and changing care models intersect to create both opportunity and complexity for clinicians, manufacturers, and health systems. The move toward minimally invasive endovascular strategies is broadening treatment candidacy and shifting resource allocation, while device developers respond with targeted innovations that address anatomical challenges and long-term durability. At the same time, commercial and policy developments, including trade dynamics and payer scrutiny, are influencing procurement strategies and go-to-market approaches.

Stakeholders that align product development with clinical evidence, invest in training and post-market surveillance, and build resilient supply chains will be best positioned to deliver patient-centered outcomes while achieving sustainable commercial performance. Embracing collaborative models with health systems and payers that emphasize value and outcomes will further enable access to advanced therapies and support the long-term viability of innovative solutions. As the landscape continues to evolve, continued monitoring of clinical data, regulatory developments, and regional care models will be essential to refine strategies and maintain alignment with emerging best practices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aortic Aneurysm Market, by Aneurysm Type

  • 8.1. Abdominal Aortic Aneurysm
    • 8.1.1. Infrarenal
    • 8.1.2. Juxtarenal
    • 8.1.3. Suprarenal
  • 8.2. Thoracic Aortic Aneurysm
    • 8.2.1. Ascending
    • 8.2.2. Descending
    • 8.2.3. Thoracoabdominal

9. Aortic Aneurysm Market, by Treatment Modality

  • 9.1. Endovascular Repair
  • 9.2. Open Surgical Repair
    • 9.2.1. Biological Conduit
    • 9.2.2. Synthetic Vascular Graft

10. Aortic Aneurysm Market, by Device Type

  • 10.1. Stent Graft
  • 10.2. Synthetic Vascular Graft

11. Aortic Aneurysm Market, by Indication

  • 11.1. Elective Repair
  • 11.2. Rupture Repair

12. Aortic Aneurysm Market, by Patient Age Group

  • 12.1. 65 And Above
  • 12.2. Under 65

13. Aortic Aneurysm Market, by Gender

  • 13.1. Female
  • 13.2. Male

14. Aortic Aneurysm Market, by End User

  • 14.1. Ambulatory Surgery Centers
    • 14.1.1. Cardiology Centers
    • 14.1.2. Standalone Surgery Centers
  • 14.2. Hospitals
    • 14.2.1. General Hospitals
    • 14.2.2. Specialized Vascular Centers
    • 14.2.3. Tertiary Care Hospitals

15. Aortic Aneurysm Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Aortic Aneurysm Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Aortic Aneurysm Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Aortic Aneurysm Market

19. China Aortic Aneurysm Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Abbott Laboratories
  • 20.6. Altura Medical Inc.
  • 20.7. Artivion, Inc.
  • 20.8. Bentley InnoMed GmbH
  • 20.9. Bolton Medical, Inc.
  • 20.10. Boston Scientific Corporation
  • 20.11. Cardinal Health company
  • 20.12. Cook Medical Inc.
  • 20.13. CryoLife, Inc.
  • 20.14. Endologix Inc.
  • 20.15. Johnson & Johnson Services, Inc.
  • 20.16. Koninklijke Philips N.V.
  • 20.17. Lemaitre Vascular Inc.
  • 20.18. LifeTech Scientific Corporation
  • 20.19. LivaNova PLC
  • 20.20. Lombard Medical, Inc.
  • 20.21. Medtronic PLC
  • 20.22. MicroPort Scientific Corporation
  • 20.23. Phenox GmbH
  • 20.24. Terumo Corporation
  • 20.25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 217. GCC AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 218. GCC AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 219. GCC AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 220. GCC AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 222. GCC AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. GCC AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 224. GCC AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 226. GCC AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. G7 AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 256. G7 AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 257. G7 AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 258. G7 AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 259. G7 AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 261. G7 AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. G7 AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 263. G7 AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. G7 AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. NATO AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 269. NATO AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 270. NATO AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 271. NATO AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 272. NATO AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 274. NATO AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 275. NATO AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 276. NATO AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. NATO AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)